Ming Chen, PhD, presented a seminar titled “Understanding and Targeting Metastatic Prostate Cancer” in the Department of Genetics at the University of Alabama at Birmingham on March 1st, 2024. A week later, he presented the same talk in the Department of Biological Sciences at the University of Notre Dame. During the presentations, Chen discussed the molecular and metabolic underpinnings of metastatic prostate cancer, as well as vulnerabilities which could be exploited to develop new and effective treatments for it.
Prostate cancer remains a pressing concern for men’s health. Every three minutes in the United States, a man will be diagnosed with prostate cancer, and each year, more than 30,000 American men will die of prostate cancer. This translates to one death from prostate cancer every 15 minutes.
Alarmingly, almost all of these fatalities stem from metastatic disease. Therefore, understanding and targeting metastatic prostate cancer could have a significant impact on reducing prostate cancer mortality rate.